News

Latest news

Global Justice Now legal challenge sees UK government criticised for secrecy over trade talks.

Published by Global Justice Now on 24 August, Nick Dearden’s new book is a comprehensive exposé of the corporate agenda behind the US trade deal.

Public health campaigners warn the government’s latest deal to secure advanced supplies of potential Covid-19 vaccines for the UK will fuel the global scramble to hoard vaccines by rich countries. (1) The government’s deals with Novavax and Janssen to purchase 90 million doses of a potential vaccine on a UK-first basis, undermines global efforts to ensure fair and world-wide access to Covid-19 vaccines. 
 

Public health and social justice organisations have warned that the government’s latest deal to secure advanced supplies of potential Covid-19 vaccines for the UK will fuel the global scramble to hoard vaccines by rich countries. The government’s move to purchase 60 million doses of a potential vaccine from pharmaceutical giants GlaxoSmithKlein and Sanofi for the UK, undermines global efforts to ensure fair and world-wide access to Covid-19 vaccines. 
 

Our reaction to the government's obesity strategy, published today.

Aid

Reaction to the news that the UK government is to make £2.9 billion of cuts to the international aid budget this year.

Public health and social justice organisations have warned that the government’s deal to secure advanced supplies of potential Covid-19 vaccines for the UK will fuel the global scramble to hoard vaccines by rich countries.

Groups in more than 90 countries warn ISDS system could be used to claim billions from governments over pandemic protections

Aid

Campaign group Global Justice Now has condemned new revelations of the UK government putting aid money into fossil fuel projects overseas. Revelations in CDC Group's annual report mean £668m of UK aid has financed fossil fuels overseas since Paris Agreement.

Reacting to US pharma company Gilead's announcement of global pricing for its remdesivir drug, Nick Dearden, director of Global Justice Now, said:

"Remdesivir is a drug which has been produced with substantial amounts of public money in the US, and which researchers have estimated could be made for $9 per treatment course (1), but here is Big Pharma company Gilead generously only charging over $2,000! While that is reduced to $600 in lower-income countries, these are still vast price tags. 

Reaction to Liz Truss’s announcement today that Britain will seek to accede to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership.

Pages